A new study, 'Sensitive poliovirus detection using nested PCR and nanopore sequencing: a prospective validation study', published today (17 August 2023) in Nature Microbiology, proves that using DDNS to detect polio outbreaks can save public health authorities crucial time and money.

United Medical Group

19.08.2023

3 Flagship biotechs make key exec hires—Chutes & Ladders

Three Flagship companies make key exec hires. Ex-Novartis cell and gene head to be new Resolution CEO. Cidara names translational science head.

United Medical Group

19.08.2023

Severe COVID-19 may cause long-term changes to innate immune system

Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to a small study funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

United Medical Group

20.08.2023

Regeneron wins FDA approval for rare immune disease med Veopoz, expects high-dose Eylea decision in the coming weeks | Fierce Pharma

Along with resolving site inspection issues that cost Regeneron a high-dose Eylea launch in June, the company has scored an FDA nod for Veopoz as the first treatment for the ultra-rare inherited im

home›United Medical Group

United Medical Group

Health

DDNS technique could reduce the time to detect polio, study shows

3 Flagship biotechs make key exec hires—Chutes & Ladders

Severe COVID-19 may cause long-term changes to innate immune system

Regeneron wins FDA approval for rare immune disease med Veopoz, expects high-dose Eylea decision in the coming weeks | Fierce Pharma

home
›
United Medical Group